Previous 10 | Next 10 |
2024-06-05 16:22:38 ET Eli Lilly ( NYSE: LLY ) shares traded in the red on Wednesday, breaking a streak of six straight days of gains. Stock closed down 0.10% at $831.76.... Read the full article on Seeking Alpha For further details see: Eli Lilly snaps six straight ...
2024-06-05 14:05:17 ET Summary Eli Lilly has been outperforming the S&P 500. The company's blockbuster drug Mounjaro has been approved in China, resulting in high demand and a strong earnings report. The five-year target price for Eli Lilly has been raised to $1,455 based ...
2024-06-05 13:44:31 ET More on LifeMD LifeMD: Moving Towards Profitability LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript LifeMD, Inc. 2024 Q1 - Results - Earnings Call Presentation LifeMD Q1 2024 Earnings Preview LifeMD Non-GAAP EPS of $0.15 be...
2024-06-05 13:10:12 ET More on Biogen, Eli Lilly, etc. Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Alphabet taps...
2024-06-05 13:00:00 ET Summary The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Albertsons, Viking Therapeutics, Brandywine Realty Trust, platinum, and more are discussed in this edition. A number of veteran Seeking Alph...
2024-06-05 08:21:51 ET Google’s parent company Alphabet ( NASDAQ: GOOG ) ( NASDAQ: GOOGL ) has tapped Anat Ashkenazi as its new chief financial officer.... Read the full article on Seeking Alpha For further details see: Alphabet taps Eli Lilly executiv...
2024-06-05 08:10:19 ET More on Eli Lilly Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly CFO Anat Ashkenaz...
2024-06-05 08:00:24 ET More on Eli Lilly Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly wins favorable terms for obesity drug use in U.K. Eli Lilly sees improving availability of GL...
Lilly announces departure of Anat Ashkenazi, chief financial officer PR Newswire INDIANAPOLIS , June 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportuni...
2024-06-04 16:02:02 ET More on Markets Goldman Sachs: Core inflation will cool to 2.2% in developed economies Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) The Reversal Of The Reversal S&P 500 Investor Focus Shif...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-18 05:23:00 ET Stock splits can sometimes be an effective way for a company to generate excitement around its stock. It's a sign that the company is doing well, and by lowering the price of the stock through a split, the shares can become more accessible to a wider pool of investo...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...